Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 26, 2024Scientific ReportsOpen Access

Synthetic angiotensin II peptide derivatives confer protection against cerebral and severe non-cerebral malaria in murine models

View Full Paper
Ask AI
Bookmark
Share

Authors

ASAdriana F. SilvaMTMarcelo D. T. TorresLSLeandro S. Silva

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Silva et al. (2024) studied this question.

synapsesocial.com/papers/68e778d3b6db6435876ed47ehttps://doi.org/10.1038/s41598-024-51267-5
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Angiotensin II Moderately Decreases Plasmodium Infection and Experimental Cerebral Malaria in Mice2015 · 23 citations
  2. 2Investigating angiotensin II concentration in modulating Plasmodium falciparum infection and angiotensin receptor activation2026
  3. 3Impairment of the Plasmodium falciparum Erythrocytic Cycle Induced by Angiotensin Peptides2011 · 60 citations
  4. 4Targeting Angiotensin II Type-1 Receptor (AT1R) Inhibits the Harmful Phenotype of Plasmodium-Specific CD8+ T Cells during Blood-Stage Malaria2017 · 15 citations
  5. 5Angiotensin II Is a New Component Involved in Splenic T Lymphocyte Responses during Plasmodium berghei ANKA Infection2013 · 34 citations